U.S. Chemical Peel Market Revenue & Forecast Analysis, 2026-2035

The U.S. chemical peel market was evaluated at USD 771.36 million in 2025 and is projected to grow at a CAGR of 5.7% from USD 810.62 million in 2026 to USD 1333.85 million in 2035. The market expansion is primarily driven by the increasing demand for non-invasive aesthetic procedures, as consumers seek effective solutions for acne scars, hyperpigmentation, wrinkles, and skin rejuvenation without undergoing surgery. Additionally, rising consumer awareness regarding skincare, growing adoption of anti-aging treatments, and the expanding network of dermatology clinics and medical spas are supporting the growth of the U.S. chemical peel market.

Published: June 22, 2026
100 Pages

Market Overview

According to a 2023 study published in the Journal of Cosmetic Dermatology, a combination chemical peel containing trichloroacetic acid and lactic acid demonstrated effectiveness in improving mild-to-moderate facial skin aging among U.S. patients, highlighting the growing clinical acceptance of chemical peels for skin rejuvenation treatments in the United States.

The U.S. chemical peel market has grown steadily over the years, supported by continuous product innovation, increasing availability of customised peel formulations, and the expansion of professional aesthetic treatment offerings across skincare clinics and wellness centers. The introduction of advanced peel solutions targeting specific skin concerns has further strengthened market penetration and consumer adoption. For instance, in January 2024, PCA Skin launched its Pigment Correct Peel, a formulation designed to address visible hyperpigmentation across all Fitzpatrick skin types, reflecting ongoing innovation in chemical peel technologies and contributing to market growth.

The U.S. chemical peel market is projected to experience significant growth throughout the forecast period due to increasing investments in aesthetic healthcare infrastructure, expanding access to personalised cosmetic treatments, and the growing integration of skincare services within wellness and preventive care programs. The rising adoption of combination aesthetic procedures is also contributing to market expansion. For instance, by 2035, U.S. dermatology and aesthetic providers are expected to broaden customised peel-based treatment offerings to address diverse patient needs and improve treatment outcomes.

U.S. Chemical Peel Market Overview

Base Year Market Size (2025): USD 771.36 Million

CAGR: 5.7%

Forecast Year Market Size (2035): USD 1,333.85 Million

Major Players:

  • Allergan Aesthetics (SkinMedica)

  • PCA Skin

  • Obagi Medical

  • IMAGE Skincare

  • Galderma.

U.S. Chemical Peel Market Trends

The U.S. chemical peel market is evolving rapidly due to changing consumer preferences in aesthetic dermatology, advancements in treatment customization, and the growing focus on inclusive skincare solutions.

  • The increasing demand for chemical peels formulated for diverse skin tones is encouraging manufacturers to develop products that minimise the risk of post-inflammatory hyperpigmentation.

  • The growing use of multi-acid and blended peel formulations is enabling practitioners to address multiple skin concerns simultaneously while improving treatment precision.

  • The rising popularity of preventive aesthetic treatments among younger consumers is expanding the patient base for professional chemical peel procedures.

  • The increasing incorporation of chemical peels into comprehensive skincare regimens is driving demand for treatment protocols that combine in-clinic procedures with physician-recommended skincare products.

Collectively, these trends are expected to support the continued growth of the U.S. chemical peel market by expanding treatment accessibility, improving clinical effectiveness, and strengthening patient engagement.

U.S. Chemical Peel Market Analysis

By Type

Superficial Peels dominate the U.S. chemical peel market due to their broad applicability and minimal recovery time

Based on type, the U.S. chemical peel market is categorised into superficial peels (light peels), medium peels, and deep peels. The superficial peels segment leads the market with the highest market share in 2025.

By Product

Lactic Peels dominate the U.S. chemical peel market owing to their suitability for diverse skin types

Based on product, the U.S. chemical peel market is categorised into beta peels, glycolic peels, lactic peels, pigment balancing peels, TCA peels, and resorcinol peels. The lactic peels segment leads the market with the highest market share in 2025.

By Application

Inflammatory Disorders dominate the U.S. chemical peel market due to the high demand for acne-related treatments

Based on application, the U.S. chemical peel market is categorised into pigmentary disorders, inflammatory disorders, chronoaging, and pre-cancerous lesions. The inflammatory disorders segment leads the market with the highest market share in 2025.

Key Companies Profiled

The U.S. chemical peel market features a competitive landscape with leading aesthetic skincare and dermatology companies competing through innovative peel formulations, professional skincare solutions, and physician-dispensed treatment portfolios. Key players such as Allergan Aesthetics (SkinMedica), PCA Skin, Obagi Medical, IMAGE Skincare, and Galderma hold a significant share of the market, supported by strong brand recognition, extensive provider networks, and continuous product development.

The market is highly competitive, with companies focusing on specialised peel formulations, skin-brightening treatments, acne management solutions, and integrated skincare regimens to strengthen their market positions. The increasing demand for professional aesthetic procedures, evolving consumer preferences, and continuous advancements in cosmetic dermatology are further intensifying competition across the market.

U.S. Chemical Peel Market Companies:

Some of the key companies operating in the U.S. Chemical Peel Market include:

  • Alastin Skincare

  • Allergan Aesthetics (SkinMedica)

  • Dermalogica

  • Epionce

  • Galderma (Glytone)

  • GlyMed Plus

  • IMAGE Skincare

  • Jan Marini Skin Research

  • Lira Clinical

  • NeoStrata Company

  • Obagi Medical

  • PCA Skin

  • Revision Skincare

  • Skin Script

  • ZO Skin Health

Market Segmentation

This study provides revenue growth and emerging trends across the U.S. levels from 2021 to 2035, segmenting the U.S. chemical peel market by-

Type (Revenue in USD Million, 2021 - 2035)

  • Superficial Peel (Light Peel)

  • Medium Peel

  • Deep Peel

Product (Revenue in USD Million, 2021 - 2035)

  • Beta Peel

  • Glycolic Peel

  • Lactic Peel

  • Pigment Balancing Peel

  • TCA Peel

  • Resorcinol Peel

Application (Revenue in USD Million, 2021 – 2035)

  • Pigmentary Disorders

    • Lentigines

    • Ephelides

    • Melasma

  • Inflammatory Disorders

    • Acne

    • Rosacea

    • Scars

  • Chronoaging

  • Pre-cancerous Lesions

Table of Content

1. Methodology and Scope

1.1. Scope of the Study

1.1.1. Market Segmentation

1.1.2. Market Definition

1.1.3. Inclusions and Exclusions of the Study

1.2. Research Design

1.2.1. Base Year, Historical Data, and Forecast Period

1.2.2. Data Collection Methods

1.2.2.1. Secondary Sources

1.2.2.2. Primary Sources

1.2.3. Research Methodology

1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)

1.2.3.2. Volume-Price Approach (Bottom-up Approach)

1.2.3.3. Data Triangulation

1.2.4. Forecasting Model

1.3. Research Assumptions

1.4. Validation and Data Quality Control

1.5. List of Primary Sources

1.6. List of Secondary Sources

2. Executive Summary

2.1. Market Overview

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

3. Industry Outlook

3.1. Industry Ecosystem Analysis

3.2. Parent/ Ancillary Market Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints/ Challenges

3.3.3. Opportunities

3.4. Value Chain Analysis

3.5. Technology Roadmap

3.6. Porters Analysis

3.7. PESTLE Analysis

4. Market Estimates and Forecasts, By Type, 2021 - 2035 (Market Size in USD Mn)

4.1. Superficial Peel (Light Peel)

4.2. Medium Peel

4.3. Deep Peel

5. Market Estimates and Forecasts, By Product, 2021 – 2035 (USD Mn)

5.1. Beta Peel

5.2. Glycolic Peel

5.3. Lactic Peel

5.4. Pigment Balancing Peel

5.5. TCA Peel

5.6. Resorcinol Peel

6. Market Estimates and Forecasts, By Application, 2021 – 2035 (USD Mn)

6.1. Pigmentary Disorders

6.1.1. Lentigines

6.1.2. Ephelides

6.1.3. Melasma

6.2. Inflammatory Disorders

6.2.1. Acne

6.2.2. Rosacea

6.2.3. Scars

6.3. Chronoaging

6.4. Pre-cancerous Lesions

7. Market Estimates and Forecasts, By U.S., 2021 - 2035 (USD Mn)

7.1.1. U.S.

7.1.1.1. U.S. Chemical Peel Market Estimates and Forecasts to 2035 (USD Mn)

7.1.1.2. Market Dynamics

7.1.1.3. Competitive Landscape

7.1.1.4. Regulatory Framework

7.1.1.5. Reimbursement Scenario

8. Competitive Landscape

8.1. Company Market Share Analysis, 2025

8.2. Company Tier Structure

8.3. List of Major Suppliers, By Key Countries

8.4. Key Company Positioning Analysis

8.5. Company Profile

8.5.1. Alastin Skincare

8.5.2. Allergan Aesthetics (SkinMedica)

8.5.3. Dermalogica

8.5.4. Epionce

8.5.5. Galderma (Glytone)

8.5.6. GlyMed Plus

8.5.7. IMAGE Skincare

8.5.8. Jan Marini Skin Research

8.5.9. Lira Clinical

8.5.10. NeoStrata Company

8.5.11. Obagi Medical

8.5.12. PCA Skin

8.5.13. Revision Skincare

8.5.14. Skin Script

8.5.15. ZO Skin Health

9. Analyst Perspective

10. Related Reports

Related Research

Blood Clot Retrieval Devices Market Revenue & Forecast Analysis, 2026-2035

July 16, 2026View

Radiofrequency Skin Rejuvenation Devices Market Revenue & Forecast Analysis, 2026-2035

July 16, 2026View

Plaque Modification Devices Market Revenue & Forecast Analysis, 2026-2035

July 13, 2026View

Revolution Insights Briefs

Stay informed with updates on related market reports and key industry topics.